Abstract:Background: Wolfram syndrome type 1 gene (WFS1), which encodes a transmembrane structural protein (wolframin), is essential for several biological processes, including proper inner ear function. Unlike the recessively inherited Wolfram syndrome, WFS1 heterozygous variants cause DFNA6/14/38 and wolfram-like syndrome, characterized by autosomal dominant nonsyndromic hearing loss, optic atrophy, and diabetes mellitus. Here, we identified two WFS1 heterozygous variants in three DFNA6/14/38 families using exome sequencing. We reveal the pathogenicity of the WFS1 variants based on three-dimensional (3D) modeling and structural analysis. Furthermore, we present cochlear implantation (CI) outcomes in WFS1-associated DFNA6/14/38 and suggest a genotype-phenotype correlation based on our results and a systematic review. Methods: We performed molecular genetic test and evaluated clinical phenotypes of three WFS1-associated DFNA6/14/38 families. A putative WFS1-NCS1 interaction model was generated, and the impacts of WFS1 variants on stability were predicted by comparing intramolecular interactions. A total of 62 WFS1 variants associated with DFNA6/14/38 were included in a systematic review. Results: One variant is a known mutational hotspot variant in the endoplasmic reticulum (ER)-luminal domain WFS1(NM_006005.3) (c.2051 C > T:p.Ala684Val), and the other is a novel frameshift variant in transmembrane domain 6 (c.1544_1545insA:p.Phe515LeufsTer28). The two variants were pathogenic, based on the ACMG/AMP guidelines. Three-dimensional modeling and structural analysis show that non-polar, hydrophobic substitution of Ala684 (p.Ala684Val) destabilizes the alpha helix and contributes to the loss of WFS1-NCS1 interaction. Also, the p.Phe515LeufsTer28 variant truncates transmembrane domain 7-9 and the ER-luminal domain, possibly impairing membrane localization and C-terminal signal transduction. The systematic review demonstrates favorable outcomes of CI. Remarkably, p.Ala684Val in WFS1 is associated with early-onset severe-to-profound deafness, revealing a strong candidate variant for CI. Conclusions: We expanded the genotypic spectrum of WFS1 heterozygous variants underlying DFNA6/14/38 and revealed the pathogenicity of mutant WFS1, providing a theoretical basis for WFS1-NCS1 interactions. We presented a range of phenotypic traits for WFS1 heterozygous variants and demonstrated favorable functional CI outcomes, proposing p.Ala684Val a strong potential marker for CI candidates.

A Wolfram-like syndrome family: Case report

[Wolfram-like syndrome: a case report]

The Novel Compound Heterozygous Mutations, V434del and W666X, in WFS1 Gene Causing the Wolfram Syndrome in a Chinese Family

Wolfram syndrome type 1: a case series

Wolfram Syndrome Type I Case Report and Review-Focus on Early Diagnosis and Genetic Variants

Clinical Analysis of One Case of Wolfram Syndrome Caused by Atypical Genetic Mutations and Literature Review

Two novel mutations of WFS1 gene in a Chinese family with Wolfram syndrome

Case report: De novo pathogenic variant in WFS1 causes Wolfram-like syndrome debuting with congenital bilateral deafness

WFS1 autosomal dominant variants linked with hearing loss: update on structural analysis and cochlear implant outcome

Beyond Vision and Hearing: A Case Report of Wolfram Syndrome

Heterogeneous mutations of Wolfram syndrome I gene responsible for low frequency nonsyndromic hearing loss]

Wolfram Syndrome 1: A Neuropsychiatric Perspective on a Rare Disease

Mutation analysis of the WFS1 gene in a Chinese family with autosomal-dominant non-syndrome deafness

Novel WFS1 Variants in Two Moroccan Families with Wolfram Syndrome

Clinical Characteristics and Audiological Profiles of Patients with Pathogenic Variants of WFS1

Identification of novel mutations in WFS1 and genotype-phenotype correlation in Wolfram syndrome

Expanding the spectrum of white matter abnormalities in Wolfram syndrome: A retrospective review

Complex clinical manifestations and new insights in RNA sequencing of children with diabetes and WFS1 variants

Novel WFS1 Mutations in Patients with Low-to-middle Frequency Hearing Loss.

Prevalence and phenotypic features of diabetes due to recessive, non-syndromic WFS1 mutations

Novel WFS1 variants are associated with different diabetes phenotypes